Breast Cancer Clinical Trial
Official title:
A Multidisciplinary Protocol for Planned Skin-Preserving Delayed Breast Reconstruction for Patients With Locally Advanced Breast Cancer Requiring Postmastectomy Radiation Therapy
The goal of this clinical research study is to learn if delayed-delayed breast reconstruction in women who require post-mastectomy radiation therapy will improve cosmetic outcomes and result in fewer complications compared to the standard approach (reconstruction that is not started until radiation treatment is completed).
Study Visits and Surgeries:
You will be hospitalized 2-4 times for 1-5 days depending on your condition. If you agree to
take part in this study, you will be scheduled for a skin-sparing mastectomy. The following
tests and procedures will be performed:
Pre-Operative Visit:
- Your complete medical history will be updated.
- The doctor will determine what type of reconstructive surgery can be done.
- You will have photos taken of your breasts. Your face, hair, or jewelry will not be
photographed. These photos will be kept in a password-protected computer accessible
only by the principle investigator and people directly involved in this study.
- You will complete a quality of life questionnaire. The questionnaire asks about how
satisfied you are with your appearance. The questionnaire will be sent by email, US
postal service mail, or in person when you come for your follow up visits. The
questionnaire should take about 20 minutes to complete. If sent by US postal service,
you will be given a postage-paid envelope to return the questionnaire.
At your Mastectomy Surgery:
- Your complete medical history will be updated.
- You will have photos taken of your breasts.
- During the surgery, a tissue expander will be placed in your breast. Sterile salt water
will be added to inflate the expander and a small skin sample (about the size of a
pencil eraser) from the breast will be taken to study stretching and scarring of the
skin. The tissue will be securely maintained at MD Anderson.
- You will be monitored for any problems.
Post-Operative Visit - 7 to 10 Days after Mastectomy Surgery:
- The study staff will look at the results of your surgery.
- Your complete medical history will be updated.
- You will complete the quality of life questionnaire.
- You will be asked about any problems you may be having.
Deflation Visit - Week 5:
- Your complete medical history will be updated.
- You will have photos taken of your breasts.
- The sterile salt water in the expander will be let out, causing the breast to go flat.
This is done by inserting a needle into a special port and withdrawing the fluid with a
syringe.
Radiation Visit - Week 8:
- You must have radiation either at M. D. Anderson or an M. D. Anderson-affiliated site.
- Extra fluid may be added to the tissue expander before radiation.
- The study staff will look at the results of your surgery.
- You will be asked about any problems you may be having.
- You will receive radiation, typically 5 days a week for 6 weeks.
Post-Radiation Visits - About Week 13 and every 2 to 4 Weeks after:
- Your complete medical history will be updated.
- The study staff will look at the results of your surgery.
- You will be asked about any problems you may be having.
- You will complete the quality of life questionnaire.
- Your expander will be re-inflated.
Delayed-delayed Reconstruction Surgery - At about Week 23:
- Your complete medical history will be updated.
- You will have photos taken of your breasts.
- During surgery, you will be monitored for any problems. A tissue sample will be
collected to study stretching and scarring of the skin from the mastectomy incision and
the tissue that is used to form the new breast. The tissue will be securely maintained
at MD Anderson.
- During surgery, you will have tissue moved from your lower abdomen, back, or buttock to
be used for reconstruction. A silicone or saline breast implant may or may not be used
to help construct the breast. The amount of tissue used for building the breast will
depend on your body size and donation site. Your reconstructive surgeon will discuss
this with you before surgery.
- During surgery, the expander will be removed and reconstruction of your breast will
occur.
Follow-Up Surgery - At about Week 47:
- Your complete medical history will be updated.
- You will have photos taken of your breasts.
- You will complete the quality of life questionnaire.
- During surgery, you will be monitored for any problems and a tissue sample will be
collected.
- During this surgery, procedures will be done to improve the appearance of the breast.
Long-Term Follow-Up Visits - At 6, 12, 24, and 36 Months:
- Your complete medical history will be updated.
- You will have photos taken of your breasts.
- You will be asked about any problems you may be having.
- At Months 12 and 24, you will complete the quality of life questionnaire.
This is an investigational study. The implants in this study have been FDA approved for skin
expansion as a method of breast reconstruction. The use of the implants is investigational
in this study.
Up to 200 women will take part in this study. All will be enrolled at M. D. Anderson.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |